The Human CEO Podcast, Helen Springford PodBean, January 2021 Focusing on approach to leadership, challenges faced and how to overcome them, also asking what it takes to be a good leader. “I get a lot of very positive feedback from my emails that I send out saying they really appreciate […]
In the Media
Experience with Mobile Research Nursing (PM360, Dec20)
In a Medidata survey conducted in April 2020, nearly 70% of investigative site personnel indicated that COVID-19 affected their ability to conduct ongoing studies and 78% believed that the pandemic impacted their ability to initiate new trials.2 And yet, according to a report released by Greenphire in October 2020, patient […]
Colours of Change (International Clinical Trials Magazine, Dec20)
Some time ago, a survey was conducted on clinical trial professionals to determine what concerns worried the industry most. Experts were consulted from far and wide within pharmaceutical company sponsors, contract research organisations, site representatives and vendors. Despite all the great work by these collective groups, an overwhelming number of studies fail for the simple reason, that not […]
This time its personal (Rare Revolution, October 20)
This originally appeared in RARE Revolution Magazine Issue No. 17 By Jessica Zeigler, Head of US Proposals When Jessica took a break from her career to devote her time to supporting her daughter Amelia, who has NOD2-associated autoinflammatory disease, she never expected that her unique insight into rare disease would […]
Pandemic spotlights the rise of mobile research nursing (Pharmaceutical Commerce, August 2020)
The impact of the COVID-19 pandemic on clinical trials has been well chronicled in recent months, with new and ongoing studies targeting a number of diseases, particularly chronic conditions, being hit hard by reductions in patient participation. This has shifted fundamental approaches in clinical operations, with some pharma sponsors turning to digital […]
The human side of oncology clinical trials (Journal for Clinical Studies, May 2020)
In this article I am going to ignore the typical metrics that are cited, such as the importance of clinical trial data being entered into the database, time to market and the cost of patient exclusivity. Instead, I shall focus on the influence of developing a truly patient-focused clinical trial, […]
Pushing ‘go’ again on clinical trials in a post Covid-19 world (International Clinical Trials Mag, May 2020)
What we do know is across several weeks of fire-fighting to respond to the immediate situation, clinical trial sponsors have not yet got to thinking about what happens next. Clearly the current challenges are daunting. There’s a lot that needs to happen before we start thinking about patients travelling to […]